{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:58:55Z","timestamp":1785405535297,"version":"3.56.0"},"reference-count":43,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"unspecified","delay-in-days":119,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Herpes zoster (HZ) and its complication, postherpetic neuralgia (PHN), disproportionately affect older adults and impose a considerable disease and economic burden. Although the Korea Disease Control and Prevention Agency recommends vaccination for adults aged \u226550\u00a0years, uptake remains limited. This study assessed the epidemiologic and economic impact of expanding vaccine coverage through inclusion of the live-attenuated zoster vaccine (ZVL) and the recombinant zoster vaccine (RZV) in the National Immunization Program (NIP). Using the incidence data from the Health Insurance Review and Assessment Service Open Statistics, along with vaccine effectiveness, coverage rates, and treatment cost estimates adjusted to 2025 values, we projected cases averted and associated cost savings. At the current 10% coverage, ZVL and RZV were estimated to prevent 36269 and 56681 HZ cases and 15988 and 20712 PHN cases, yielding societal cost savings of USD 78.47 million and USD 107.14 million, respectively. Expanding NIP coverage to 70% amplified benefits approximately sevenfold, yielding cost savings of USD 549.34 million (ZVL) and USD 749.98 million (RZV). These results demonstrate the substantial value of zoster vaccination and underscore the need for policy measures to improve vaccine coverage among older adults in South Korea.<\/jats:p>","DOI":"10.1017\/s0950268826101502","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:44:07Z","timestamp":1777535047000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiologic and economic impact of introducing a National Immunization Program for herpes zoster vaccination on the prevention of herpes zoster and postherpetic neuralgia in South Korea, an ageing society"],"prefix":"10.1017","volume":"154","author":[{"given":"Gahee","family":"Kim","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01wjejq96","id-type":"ROR","asserted-by":"publisher"}],"name":"Yonsei University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehee","family":"Jung","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01wjejq96","id-type":"ROR","asserted-by":"publisher"}],"name":"Yonsei University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dain","family":"Lee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01wjejq96","id-type":"ROR","asserted-by":"publisher"}],"name":"Yonsei University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Do","family":"Yang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01wjejq96","id-type":"ROR","asserted-by":"publisher"}],"name":"Yonsei University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3260-2623","authenticated-orcid":false,"given":"Hye-Young","family":"Kang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01wjejq96","id-type":"ROR","asserted-by":"publisher"}],"name":"Yonsei University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"S0950268826101502_r4","unstructured":"[4] Health Insurance Review and Assessment Service (HIRA) Open Statistics. https:\/\/opendata.hira.or.kr\/op\/opc\/olap3thDsInfoTab1.do (accessed 22 July 2025)."},{"key":"S0950268826101502_r6","first-page":"2344983","article-title":"A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific","volume":"20","author":"Chen","year":"2024","journal-title":"Infectious Diseases and Therapy"},{"key":"S0950268826101502_r35","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2554488"},{"key":"S0950268826101502_r20","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(22)00039-3"},{"key":"S0950268826101502_r11","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-012-0452-1"},{"key":"S0950268826101502_r14","unstructured":"[14] Ministry of Food and Drug Safety. Korea Pharmaceutical Integrated Information System. https:\/\/nedrug.mfds.go.kr\/index (accessed 20 July 2025)."},{"key":"S0950268826101502_r36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"S0950268826101502_r16","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2023.0072"},{"key":"S0950268826101502_r28","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.7431"},{"key":"S0950268826101502_r8","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200211000-00002"},{"key":"S0950268826101502_r17","unstructured":"[17] Choi, WS , et al. (2019) Cost-Effectiveness Analysis of Introducing the Zoster Vaccine into National Immunization Program in the Republic of Korea. KDCA Policy Research Report. Korea Disease Control and Prevention Agency. https:\/\/library.nih.go.kr\/ncmiklib\/archive\/rom\/reportView.do (accessed 10 September 2025)."},{"key":"S0950268826101502_r18","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2015.27.5.531"},{"key":"S0950268826101502_r34","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"S0950268826101502_r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.101923"},{"key":"S0950268826101502_r7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02089.x"},{"key":"S0950268826101502_r1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp013211"},{"key":"S0950268826101502_r3","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1603985"},{"key":"S0950268826101502_r9","unstructured":"[9] Centers for Disease Control and Prevention (CDC) Shingles (Herpes Zoster): Clinical Signs and Complications. https:\/\/www.cdc.gov\/shingles\/hcp\/clinical-signs\/index.html#cdc_hcp_clinical_complications-complications. (accessed 22 July 2025)."},{"key":"S0950268826101502_r38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.05.016"},{"key":"S0950268826101502_r33","doi-asserted-by":"publisher","DOI":"10.7326\/M18-2347"},{"key":"S0950268826101502_r31","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz219"},{"key":"S0950268826101502_r41","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1055\/a-2663-0166","article-title":"Seasonality of herpes zoster and herpes zoster ophthalmicus in Germany - a 14-year single Centre study","volume":"242","author":"Diehl","year":"2025","journal-title":"Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"},{"key":"S0950268826101502_r37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"S0950268826101502_r21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.978203"},{"key":"S0950268826101502_r43","doi-asserted-by":"publisher","DOI":"10.54724\/lc.2022.e2"},{"key":"S0950268826101502_r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127648"},{"key":"S0950268826101502_r26","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-019-00491-6"},{"key":"S0950268826101502_r15","unstructured":"[15] Korea Disease Control and Prevention Agency. Herpes Zoster. (https:\/\/nip.kdca.go.kr\/irhp\/infm\/goVcntInfo.do?menuLv=1&menuCd=1117) (accessed 10 September 2025)."},{"key":"S0950268826101502_r12","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1324373"},{"key":"S0950268826101502_r39","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2019.31.4.486"},{"key":"S0950268826101502_r27","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-024-00483-w"},{"key":"S0950268826101502_r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2023.100397"},{"key":"S0950268826101502_r23","unstructured":"[23] National Health Insurance Service Status of Determination of Medical Cost Conversion Index by Year. https:\/\/www.nhis.or.kr\/announce\/wbhaec11413m01.do (accessed 21 May 2025)."},{"key":"S0950268826101502_r25","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1754702"},{"key":"S0950268826101502_r5","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae535"},{"key":"S0950268826101502_r30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab121"},{"key":"S0950268826101502_r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104306"},{"key":"S0950268826101502_r2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00894-y"},{"key":"S0950268826101502_r24","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(17)30234-7"},{"key":"S0950268826101502_r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2025.103046"},{"key":"S0950268826101502_r42","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1558689"},{"key":"S0950268826101502_r19","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12080886"},{"key":"S0950268826101502_r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.3200"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268826101502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:04:58Z","timestamp":1784271898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268826101502\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":43,"alternative-id":["S0950268826101502"],"URL":"https:\/\/doi.org\/10.1017\/s0950268826101502","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e62"}}